Progenika Gives Grifols Rights to Distribute Bloodchip | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Spanish biotech Progenika Biopharma has granted exclusive worldwide distribution rights to Grifols for its Bloodchip product line, Progenika announced today.

The chips are used for genotyping blood donors to assure compatibility between donor and recipient. Progenika and the Bloodgen Consortium, which consists of European blood banks and research institutes, developed the chips.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.